Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/10/24 20:38 | 4/8/24 | ONCT | Health | Drug | Pharmaceutical Preparations | Wills Robert James | CA | D | P | 28 | 8.96 | 0 | 3 | 45 | 10 | D | |||||||||||||||
4/1/24 19:00 | 3/28/24 | ONCT | Health | Drug | Pharmaceutical Preparations | Wills Robert James | CA | D | P | 59 | 8.48 | 0 | 7 | New | 7 | D | |||||||||||||||
2/27/24 17:03 | 2/23/24 | ONCT | Health | Drug | Pharmaceutical Preparations | Hale David F | CA | D | P | 9 | 9.04 | 0 | 1 | 3 | 31 | M | |||||||||||||||
6/14/23 16:00 | 6/12/23 | ONCT | Health | Drug | Pharmaceutical Preparations | Kaufmann Gunnar F. | CA | O | Chief Sc | P.m | 10 | 0.3509 | 0 | 28 | 42 | 95 | D | ||||||||||||||
4/17/23 06:00 | 4/13/23 | ONCT | Health | Drug | Pharmaceutical Preparations | Breitmeyer James B | CA | DO | CEO | P.m | 44 | 0.2929 | 0 | 150 | 24 | 763 | I | ||||||||||||||
4/14/23 18:02 | 4/12/23 | ONCT | Health | Drug | Pharmaceutical Preparations | Yazji Salim | CA | O | Chief Me | P.m | 7 | 0.2880 | 0 | 25 | 18 | 165 | D | ||||||||||||||
4/14/23 06:00 | 4/12/23 | ONCT | Health | Drug | Pharmaceutical Preparations | Leavitt Chase C. | CA | O | GC,Secre | P.m | 7 | 0.2900 | 0 | 25 | 31 | 107 | D | ||||||||||||||
4/14/23 06:00 | 4/13/23 | ONCT | Health | Drug | Pharmaceutical Preparations | Vincent Richard G | CA | O | CFO | P | 9 | 0.2987 | 0 | 30 | 23 | 163 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |